Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.7K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

2.0K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

102
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of stereotactic radiosurgery in the management of brain metastases in patients with metastatic melanoma.

The British journal of radiology·2026
Same author

Myocardial fibrosis occurs in non-hospitalised patients with chronic symptoms after COVID-19.

International journal of cardiology. Heart & vasculature·2022
Same author

Correction: The Relative Contribution of Metabolic and Structural Abnormalities to Diastolic Dysfunction in Obesity.

International journal of obesity (2005)·2019
Same author

The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity.

International journal of obesity (2005)·2017
Same author

Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome.

Open heart·2017
Same author

Screening and risk assessment for coronary artery disease in HIV infection: an unmet need.

HIV medicine·2016

Related Experiment Video

Updated: Apr 30, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

11.9K

Cardiovascular disease in human immunodeficiency virus.

S Cheruvu1, C J Holloway

  • 1St Vincent's Hospital, Sydney, New South Wales, Australia.

Internal Medicine Journal
|April 24, 2014
PubMed
Summary

Human immunodeficiency virus (HIV) is manageable, but antiretroviral therapy increases cardiac risks. Proactive cardiovascular care is essential for HIV patients in Australia to ensure long-term health.

Keywords:
HIVantiretroviral therapycardiovascular diseasecardiovascular screening

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

14.1K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

7.5K

Related Experiment Videos

Last Updated: Apr 30, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

11.9K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

14.1K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

7.5K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Human immunodeficiency virus (HIV) is now a chronic, treatable condition with improved life expectancy.
  • Highly active antiretroviral therapy (HAART) effectively suppresses HIV but is linked to increased cardiac issues.
  • Traditional cardiac risk factors and heart disease incidence are concerns in patients on HAART.

Purpose of the Study:

  • To review the relationship between HIV, HAART, and cardiovascular disease (CVD).
  • To focus on contemporary screening, prevention, and treatment strategies for CVD in Australian HIV patients.

Main Methods:

  • Literature review of studies on HIV, HAART, and cardiovascular outcomes.
  • Analysis of current management guidelines and clinical practices in Australia.
  • Focus on risk factors, screening protocols, and therapeutic interventions.

Main Results:

  • HAART is associated with increased risks of hyperlipidaemia, diabetes, and both ischaemic and non-ischaemic heart disease.
  • A significant interplay exists between HIV infection, specific antiretroviral drugs, and accelerated atherosclerosis.
  • Contemporary Australian HIV management requires integrated cardiovascular risk assessment and management.

Conclusions:

  • Active prevention and treatment of cardiovascular risk are crucial for HIV-positive individuals.
  • A comprehensive strategy addressing both HIV and cardiovascular health is necessary.
  • Further research and updated clinical guidelines are needed for optimal patient outcomes.